Our top resource picks

Article
Key considerations when patenting bispecific antibodies in Europe
Technology overview Bispecific monoclonal antibodies (BsAbs) are antibody constructs that create additional strategies in designing therapeutic avenues due to their ability to bind two different targets as a single molecule. BsAbs may bind two different antigens or two different epitopes...
Learn more-
Article
Key considerations when patenting bispecific antibodies in Europe
Technology overview Bispecific monoclonal antibodies (BsAbs) are antibody constructs that create additional...
-
Article
Webinar: European design reforms from 1 May 2025
Reform of designs in the EU is now in full swing, with...
-
Article
Key considerations when patenting chimeric antigen receptor technologies in Europe
We explore the therapeutic indications addressed by Chimeric Antigen Receptors (CARs) and...
-
Article
Patenting AI innovations in healthcare: navigating European patent law
Artificial intelligence (AI) is revolutionising the healthcare industry by enhancing our ability...
All resources
Filters